JPS63503113A - 接触一抑制性因子の製造法 - Google Patents

接触一抑制性因子の製造法

Info

Publication number
JPS63503113A
JPS63503113A JP62503007A JP50300787A JPS63503113A JP S63503113 A JPS63503113 A JP S63503113A JP 62503007 A JP62503007 A JP 62503007A JP 50300787 A JP50300787 A JP 50300787A JP S63503113 A JPS63503113 A JP S63503113A
Authority
JP
Japan
Prior art keywords
cells
contact
cif
tumor
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62503007A
Other languages
English (en)
Japanese (ja)
Inventor
ローゼンバーグ，マーティン　ジェイ
リプキン，ジョージ
Original Assignee
ニューヨーク　ユニバーシィティ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニューヨーク　ユニバーシィティ filed Critical ニューヨーク　ユニバーシィティ
Publication of JPS63503113A publication Critical patent/JPS63503113A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP62503007A 1986-04-23 1987-04-21 接触一抑制性因子の製造法 Pending JPS63503113A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85604086A 1986-04-23 1986-04-23
US856,040 1986-04-23

Publications (1)

Publication Number Publication Date
JPS63503113A true JPS63503113A (ja) 1988-11-17

Family

ID=25322737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62503007A Pending JPS63503113A (ja) 1986-04-23 1987-04-21 接触一抑制性因子の製造法

Country Status (3)

Country Link
EP (1) EP0266414A4 (fr)
JP (1) JPS63503113A (fr)
WO (1) WO1987006589A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050124531A1 (en) * 2002-02-22 2005-06-09 New York University Biological inhibitions induced by contact inhibitory factor

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307082A (en) * 1979-07-10 1981-12-22 New York University Method for the extraction of a factor that mediates contact inhibition of cell growth
JPS58134032A (ja) * 1982-02-04 1983-08-10 Yoshiyuki Hashimoto 制癌性製剤
JPS59163315A (ja) * 1983-03-09 1984-09-14 Mitsui Pharmaceut Inc カルモフ−ル含有リポソ−ム
US4530784A (en) * 1983-08-19 1985-07-23 New York University Large scale extraction process for contact inhibitory factor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196191A (en) * 1975-09-29 1980-04-01 Burroughs Wellcome Co. Biological preparations
US4663161A (en) * 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307082A (en) * 1979-07-10 1981-12-22 New York University Method for the extraction of a factor that mediates contact inhibition of cell growth
JPS58134032A (ja) * 1982-02-04 1983-08-10 Yoshiyuki Hashimoto 制癌性製剤
JPS59163315A (ja) * 1983-03-09 1984-09-14 Mitsui Pharmaceut Inc カルモフ−ル含有リポソ−ム
US4530784A (en) * 1983-08-19 1985-07-23 New York University Large scale extraction process for contact inhibitory factor

Also Published As

Publication number Publication date
EP0266414A1 (fr) 1988-05-11
EP0266414A4 (fr) 1989-12-28
WO1987006589A1 (fr) 1987-11-05

Similar Documents

Publication Publication Date Title
US4002602A (en) Ubiquitous immunopoietic polypeptide (UBIP) and methods
Denk et al. Formation and involution of Mallory bodies (" alcoholic hyalin") in murine and human liver revealed by immunofluorescence microscopy with antibodies to prekeratin.
US4481137A (en) Glycoproteins and processes for their production
JPH04502143A (ja) 癌診断および管理における自己分泌運動性因子
Brown et al. Studies of the mechanism of iron absorption. I. Iron uptake by the normal rat
JP3502125B2 (ja) 形質転換細胞の抽出および培養ならびにそれらに対する抗体の製造
JP2002155100A (ja) 幹細胞増殖因子
JPH05504543A (ja) 悪液質誘発腫瘍と一般的に関連した異化作用で特徴付けられる生物学的活性のある物質、製剤、製造法および用途
CA2098113C (fr) Substances de nature polypeptidique pour usage therapeutique chez l'homme
Birdwell et al. Replication of Sindbis Virus IV. Electron Microscope Study of the Insertion of Viral Glycoproteins into the Surface of Infected Chick Cells
Chen et al. Epidermal growth factor and its receptors in human pancreatic carcinoma
Price et al. Shedding of tumor cell surface antigens
US4167557A (en) Ubiquitous immunopoietic polypeptide (UBIP) and methods
Jessup et al. Induction of suppressor cells by a tumor-derived suppressor factor
US4001080A (en) Production of immunological materials
JPS63503113A (ja) 接触一抑制性因子の製造法
Van Nest et al. Concanavalin A-induced agglutination and tumorigenicity in virally and spontaneously transformed cells derived from BALB/c mice
AU725218B2 (en) Immunogenic TLP composition
CA1224172A (fr) Facteur de regulation de cancers endogenes des humains, procede de preparation, compose pharmaceutique le contenant et lignees cellulaires de leucemie monocytaire
Carrel et al. Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen
Klostergaard et al. Tumoricidal effector mechanisms of murine BCG-activated macrophages: role of TNF in conjugation-dependent and conjugation-independent pathways
EP0363703A1 (fr) Procédé de production d'hybridomes humain-humain, production d'anticorps monoclonaux ou polyclonaux à partir de ceux-ci, et leur utilisation thérapeutique
US5348880A (en) Tumor associated monoclonal antibody 81AV/78
Kerrebijn et al. The effects of thymostimulin on immunological function in patients with head and neck cancer
WO1994001536A1 (fr) Immunotherapie contre le cancer realisee avec des anticorps diriges contre le profacteur de coagulation du cancer (pc)